Gene · 9123
Papers3,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer. | Sci Adv | 2026 | 41544173 | PubTator, text mining | PubMed |
| <p>Regulatory networks of HIFs in tumor‑infiltrating immune cells: From molecular mechanisms to therapeutic implications (Review)</p>. | Int J Oncol | 2026 | 41543185 | PubTator, text mining | PubMed |
| Metabolic adaptations rewire CD4+ T cells in a subset-specific manner in human critical illness with and without sepsis. | Nat Immunol | 2026 | 41540263 | PubTator, text mining | PubMed |
| An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. | J Immunother Cancer | 2026 | 41539687 | PubTator, text mining | PubMed |
| The Molecular Signature of Astrocyte Response to Hypoxia Outlines the Metabolic and Cell Survival Mechanisms for Neuroprotection. | Neurochem Res | 2026 | 41533048 | PubTator, text mining | PubMed |
| Roles of the Altitude-Adapted Immune Microenvironment in Pulmonary Vascular Remodeling in High-Altitude Pulmonary Hypertension: A Review. | Med Sci Monit | 2026 | 41530957 | PubTator, text mining | PubMed |
| The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Ovarian Serous Cystadenocarcinoma. | Reprod Sci | 2026 | 41530649 | PubTator, text mining | PubMed |
| BACH1 promotes lactate metabolism by transcriptionally upregulating LDHA and MCT4 expression to inhibit ferroptosis in intrahepatic cholangiocarcinoma cells. | Cell Signal | 2026 | 41519216 | PubTator, text mining | PubMed |
| Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastoma. | Nat Cell Biol | 2026 | 41495200 | PubTator, text mining | PubMed |
| SLC16A3 as a novel therapeutic target for overcoming radioresistance and chemoresistance in lung cancer. | Biochem Biophys Res Commun | 2026 | 41475270 | PubTator, text mining | PubMed |
| Key Early Changes in Oral Squamous Cell Carcinogenesis Are Accelerated by Ectopic BMI1 Expression. | Cancer Res Commun | 2026 | 41385756 | PubTator, text mining | PubMed |
| Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinoma. | Cancer Lett | 2026 | 41371433 | PubTator, text mining | PubMed |
| Prediction of Lung Metastasis in Breast Cancer Patients Using Machine Learning Classifiers. | J Mol Diagn | 2026 | 41318062 | PubTator, text mining | PubMed |
Molecularly Engineered Nanoagents with Efficient Free Radicals Generation and Photothermal Conversion Performance for Enhanced Tumor Photoimmunotherapy via Targeting Lactate Metabolism-Immune Circuit Rewiring. | Adv Mater | 2026 | 40952145 | PubTator, text mining | PubMed |
| Genetic and epigenetic analysis of plasma glial fibrillary acidic protein (GFAP) levels in PTSD. | Mol Psychiatry | 2026 | 40931166 | PubTator, text mining | PubMed |
| Solute carrier family 16 member 3 is a target of nodakenetin in breast cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40911046 | PubTator, text mining | PubMed |
| Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis. | Arch Med Res | 2026 | 40829205 | PubTator, text mining | PubMed |
| CXCL2 Mediates Lactate Secretion and Promotes Aortic Dissection Formation through the p38/JNK/C-myc Pathways. | Thromb Haemost | 2026 | 40398663 | PubTator, text mining | PubMed |
| Mass spectrometry in ocular drug research. | Mass Spectrom Rev | 2026 | 37530668 | PubTator, text mining | PubMed |
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9123/papers?page=7